Lara Milian
Overview
Explore the profile of Lara Milian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Oliver-Ferrandiz M, Milian L, Sancho-Tello M, de Llano J, Gisbert Roca F, Martinez-Ramos C, et al.
Biomedicines
. 2021 Aug;
9(7).
PMID: 34356898
Matrix-assisted autologous chondrocyte implantation (MACI) has shown promising results for cartilage repair, combining cultured chondrocytes and hydrogels, including alginate. The ability of chondrocytes for MACI is limited by different factors...
12.
Milian L, Sancho-Tello M, Roig-Soriano J, Foschini G, Martinez-Hernandez N, Mas-Estelles J, et al.
Int J Artif Organs
. 2021 Apr;
44(12):998-1012.
PMID: 33863248
Objective: The aim of this study was to optimize a decellularization protocol in the trachea of (pig) as well as to study the effects of long-term cryopreservation on the extracellular...
13.
Mata M, Zurriaga J, Milian L, Reula A, Armengot M, Ruiz-Sauri A, et al.
Allergy Rhinol (Providence)
. 2021 Feb;
12:2152656721989288.
PMID: 33628615
Background: Primary ciliary dyskinesia (PCD) is characterised by an imbalance in mucociliary clearance leading to chronic respiratory infections. Cilia length is considered to be a contributing factor in cilia movement....
14.
Milian L, Mata M, Alcacer J, Oliver M, Sancho-Tello M, de Llano J, et al.
PLoS One
. 2020 Feb;
15(2):e0228909.
PMID: 32049991
Background/objective: Patients with non-small cell lung cancer (NSCLC) develop resistance to antitumor agents by mechanisms that involve the epithelial-to-mesenchymal transition (EMT). This necessitates the development of new complementary drugs, e.g.,...
15.
Zurriaga Carda J, Lastra M, Antolinos-Turpin C, Morales-Roman R, Sancho-Tello M, Perea-Ruiz S, et al.
J Biomed Mater Res B Appl Biomater
. 2019 Sep;
108(4):1428-1438.
PMID: 31520507
The objective of this study was to test a regenerative medicine strategy for the regeneration of articular cartilage. This approach combines microfracture of the subchondral bone with the implant at...
16.
Estelles R, Milian L, Nabah Y, Mateo T, Cerda-Nicolas M, Losada M, et al.
J Leukoc Biol
. 2018 Jan;
78(3):696-704.
PMID: 29350806
Angiotensin-II (Ang-II) has inflammatory activity and is involved in different diseases associated with the cardiovascular system. This study has evaluated the effect of boldine (B), and two phenanthrene alkaloids semisynthesized...
17.
Mata M, Milian L, Oliver M, Zurriaga J, Sancho-Tello M, de Llano J, et al.
Stem Cells Int
. 2017 Sep;
2017:8309256.
PMID: 28951745
Osteoarthritis is an inflammatory disease in which all joint-related elements, articular cartilage in particular, are affected. The poor regeneration capacity of this tissue together with the lack of pharmacological treatment...
18.
Milian L, Peris J, Gandia P, Andujar I, Pallardo L, Gorriz J, et al.
AIDS
. 2017 Jun;
31(12):1679-1684.
PMID: 28650379
Objective: In-vivo studies suggest that mitochondria is involved in tenofovir (TFV)-induced renal toxicity, but the underlying mechanisms are still unclear. The aim of the present study was to assess the...
19.
Sancho-Tello M, Martorell S, Roig M, Milian L, Gamiz-Gonzalez M, Ribelles J, et al.
J Tissue Eng
. 2017 May;
8:2041731417697545.
PMID: 28540030
The clinical management of large-size cartilage lesions is difficult due to the limited regenerative ability of the cartilage. Different biomaterials have been used to develop tissue engineering substitutes for cartilage...
20.
Sarrion I, Milian L, Juan G, Ramon M, Furest I, Carda C, et al.
Oxid Med Cell Longev
. 2015 Mar;
2015:792846.
PMID: 25815108
Idiopathic pulmonary hypertension (IPAH) is a rare disease characterized by a progressive increase in pulmonary vascular resistance leading to heart failure. MicroRNAs (miRNAs) are small noncoding RNAs that control the...